Alphabet’s AI-powered drug discovery company, Isomorphic Labs, is preparing to take its first major leap into the real world. After years of development, the company says it’s now gearing up for human ...

Isomorphic Labs, a DeepMind spinoff, is close to starting human trials for AI-designed drugs. The company aims to speed up drug discovery, reduce costs, and improve success rates in medicine.